전체 프로그램

ADC 890 · Antibody 4097 · CGT 2985 · 다음 갱신 D-6 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved745 programs
CGTLimited DatastaleShanghai Unicar-Therapy Bio-med…Phase 1

chimeric antigen receptor T cell (chimeric antigen receptor T cell)

Pancreatic Cancer; CAR · FRα

#FR#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 62Status Active
ADCLimited DatastaleRocheDM1 via butelase-1 with ABD…Phase 3

T-DM1 (Ado-trastuzumab emtansine, Ado-trastuzumab emtansine (T-DM1))

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase3#Popular#antibody-drug-conjugate+3
Trials 61Status Recruiting
CGTStandard DatabasestaleAlliance for Clinical Trials in…Phase 3

Allopurinol (Allopurinol)

B Acute Lymphoblastic Leukemia · Fallopian Tube Cancer

#FallopianTubeCancer#CGT#Phase3#Popular#cell-gene-therapy+5
Trials 61Status Discontinued
AntibodyLimited DatastaleRochePhase 3

atezolizumab (Tecentriq, MPDL3280A, Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody)

Bladder Cancer · Bladder Cancer

#BladderCancer#Antibody#Phase3#Popular#monoclonal-antibody+1
Trials 61Status Active
CGTStandard DatabasestaleNational Cancer Institute (NCI)Phase 2

Multi-epitope (ME, Multi-epitope, Multi-epitope (ME) T-cell receptor g alternate reading frame protein (TARP) vaccine)

Prostatic Neoplasms; Prostate Cancer · FRα

#FR#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 61Status Discontinued
CGTLimited DatastaleIstituto Clinico HumanitasPreclinical

immune evaluation (immune evaluation)

Oligorecurrent and Oligoprogressive Prostate Cancer Patients · Oligorecurrent and Oligoprogressive Pros

#OligorecurrentandOligoprogressiv#CGT#Preclinical#Popular#cell-gene-therapy+4
Trials 61Status Recruiting
CGTStandard DatabasestaleGlaxoSmithKlinePhase 2

topotecan hydrochloride (topotecan hydrochloride)

Fallopian Tube Carcinosarcoma; Fallopian Tube Clear Cell Adenocarcinoma · Fallopian Tube Cancer

#FallopianTubeCancer#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 61Status Discontinued
AntibodyLimited DatastaleRochePreclinical

MPDL3280A (Atezolizumab, Atezolizumab (MPDL3280A))

Non-Small Cell Lung Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#Antibody#Preclinical#Popular#monoclonal-antibody+1
Trials 60Status Active
CGTStandard DatabasestaleEpicentRx, Inc.Phase 2

Checkpoint Inhibitor, Immune (Checkpoint Inhibitor, Immune)

Solid Tumor, Adult; Cancer · Solid Tumor, Adult

#SolidTumorAdult#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 60Status Recruiting
CGTStandard DatabasestaleMedigene AGPhase 2

Lymphodepletion (Lymphodepletion)

Epithelial Ovarian Cancer; Gastro-esophageal Junction Cancer · FRα

#FR#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 60Status Discontinued
AntibodyLimited DatastaleRochePhase 2

trastuzumab (Herceptin, Pertuzumab + trastuzumab)

Elderly Metastatic Breast Cancer Population · Elderly Metastatic Breast Cancer Populat

#ElderlyMetastaticBreastCancerPop#Antibody#Phase2#Popular#monoclonal-antibody+1
Trials 60Status Active
AntibodyLimited DatastaleSun Yat-sen UniversityPhase 3

Serplulimab (Serplulimab)

Colorectal Cancer; Liver Metastases · Solid Tumor Cancer

#SolidTumorCancer#Antibody#Phase3#Popular#monoclonal-antibody+3
Trials 60Status Recruiting
CGTLimited DatastaleMedigene AGPhase 1

MDG1015 (TCR-T cells, TCR-T cells (MDG1015))

Epithelial Ovarian Cancer; Gastro-esophageal Junction Cancer · Epithelial Ovarian Cancer

#EpithelialOvarianCancer#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 60Status Recruiting
AntibodyLimited DatastaleBristol Myers SquibbPhase 2

nivolumab (Opdivo, ipilimumab + nivolumab)

Solid Tumor; Non Small Cell Lung Cancer · Solid Tumor

#SolidTumor#Antibody#Phase2#Popular#monoclonal-antibody+2
Trials 60Status Recruiting
CGTStandard DatabasestaleGamma Medica-IdeasPhase 2

tamoxifen citrate (tamoxifen citrate)

Male Breast Cancer; Stage II Breast Cancer · Breast Cancer

#BreastCancer#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 60Status Active
AntibodyLimited DatastaleRegeneronPhase 2

Cemiplimab + Fianlimab [Fixed Dose Combination (FDC, Cemiplimab + Fianlimab [Fixed Dose Combination, Cemiplimab + Fianlimab [Fixed Dose Combination (FDC)])

Ovarian Cancer; Fallopian Tube Cancer · Ovarian Cancer

#OvarianCancer#Antibody#Phase2#Popular#monoclonal-antibody+3
Trials 59Status Recruiting
CGTLimited DatastaleCalimmune, Inc.Phase 1

Gene Modified T Cells (Gene Modified T Cells)

Colorectal Cancer · Prostate Cancer

#ProstateCancer#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 59Status Discontinued
AntibodyLimited DatastaleBristol Myers SquibbPhase 2

nivolumab (Opdivo, Ipilimumab and nivolumab)

Mesothelioma; Pancreatic Cancer · Uveal Melanoma, Metastatic

#UvealMelanomaMetastatic#Antibody#Phase2#Popular#monoclonal-antibody+3
Trials 59Status Recruiting
CGTStandard DatabasestaleImmunityBio, Inc.Phase 2

Activated NK Cells (M-CENK, M-CENK (Activated NK Cells))

High-risk Prostate Cancer · High-risk Prostate Cancer

#High-riskProstateCancer#CGT#Phase2#Popular#cell-gene-therapy+3
Trials 59Status Discontinued
CGTStandard DatabasestaleSPP Pharmaclon Ltd.Phase 2

Recombinant Interferon Alfa (Recombinant Interferon Alfa)

Colorectal Cancer; Kidney Cancer · Bladder Cancer

#BladderCancer#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 59Status Active

3 / 38 pages

← PreviousNext →